⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
globenewswire.com
RXRX
AI in Biotechnology Market Size to Reach USD 1,971 Million by 2031 | Valuates Reports
prnewswire.com
RXRX
EVGN
BNTX
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
globenewswire.com
RXRX
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
globenewswire.com
RXRX
AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
globenewswire.com
ILMN
GH
RXRX
AI-Driven Bioengineering Platforms Revolutionize Protein, Strain, and Drug Design with Multi-Billion Dollar Government Support
globenewswire.com
DNA
RXRX
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
prnewswire.com
SDGR
RXRX
TEM
LLY
$1.5 Billion AI-based Clinical Trials Market 2026-2032: Rising Investment from Biopharma Sponsors and CROs
globenewswire.com
GOOGL
INTC
IBM
AVTR
PHG
TEMP
RXRX
Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
businesswire.com
GILD
RXRX
Artificial Intelligence in Drug Repurposing Global Market Research Report 2025 with Long-term Prospects to 2029 and 2034
globenewswire.com
IBM
EVGN
DNA
RXRX
COSM